Answers are grounded in this paper and cite their sources.
Background Direct oral anticoagulants (DOACs) are first-line therapies for atrial fibrillation and venous thromboembolism. Structured pharmaceutical interviews aim to improve patient knowledge of DOAC therapy, thereby enhancing medication adherence and reducing both disease-related and drug-related clinical complications. Purpose The EDUC-AOD study was conducted to assess the impact of structured pharmaceutical interviews on patient knowledge, medication adherence, and clinical complications. Methods Patients newly prescribed DOACs were enrolled from two centers, with only one center delivering structured pharmaceutical interviews. The primary objective was to assess the effect of structured pharmaceutical interviews on both knowledge and medication adherence scores at 3 months (M3), using standardized questionnaires. Secondary objectives included evaluating the impact of structured pharmaceutical interviews on clinical complications, as well as knowledge and medication adherence at 6 months (M6). Multivariate logistic regression analysis was used to identify predictors of improved knowledge and medication adherence. Results From January 2021 to June 2023, 145 patients were enrolled: 68 in the intervention group and 77 in the control group. Among these, 127 patients completed the follow-up and were included in the analysis. At M3, the intervention group demonstrated significantly higher rates of satisfactory knowledge (74% vs. 12%, p<0.001) and good medication adherence (86% vs. 64%, p=0.008). At M6, the intervention group experienced significantly fewer hemorrhagic complications (0 vs. 9, p=0.010). Structured pharmaceutical interviews and treatment indication were identified as significant predictors of satisfactory knowledge (OR = 31, p<0.001; OR = 5, p=0.003, respectively). Conclusion Structured pharmaceutical interviews substantially enhance patients’ knowledge and medication adherence to DOAC therapy and reduce clinical complications. Integrating structured pharmaceutical interviews into routine care may optimize anticoagulant management. Further randomized trials are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: